mous
hepat
viru
mhv
either
avirul
resist
mice
hepatotrop
suscept
mice
neurotrop
semisuscept
mice
depend
strain
mice
infect
semisuscept
mice
infect
led
first
transient
mening
ependym
leukoenceph
follow
perman
commun
hydrocephalu
later
chronic
thrombot
vascul
affect
mening
parenchym
vessel
brain
stem
level
small
foci
ischem
necrosi
relat
vascular
occlus
seen
dorsal
brain
stem
cyclophosphamid
treatment
semisuscept
mice
significantli
reduc
mening
infiltr
prevent
develop
hydrocephalu
neuropatholog
chang
ident
lesion
occur
fulli
suscept
mice
infect
low
dose
viru
neurolog
disord
could
induc
genet
resist
mice
even
follow
immunosuppress
intracrani
inocul
leukoenceph
differ
demyelin
lesion
observ
mhv
vascular
lesion
particular
interest
attent
given
possibl
viru
induc
chronic
cerebr
vascul
man
differ
suscept
viru
infect
depend
characterist
inject
viru
weiner
et
al
wolinski
stroop
rout
infect
johnson
host
genet
factor
immun
function
allison
hirsch
et
al
levyleblond
et
al
mous
hepat
viru
mhv
member
corona
viru
group
either
avirul
hepatotrop
neurotrop
depend
strain
mice
infect
adult
aj
mice
fulli
resist
viru
suscept
strain
eg
balbc
develop
acut
hepat
necrosi
lead
death
within
day
mous
strain
eg
well
f
hybrid
resist
suscept
strain
exhibit
semisuscept
result
either
earli
death
surviv
anim
develop
chronic
diseas
neurolog
manifest
viru
persist
dupuy
et
al
le
prevost
et
al
b
ependym
vascul
report
suscept
resist
mhv
infect
shown
influenc
least
two
major
gene
complex
one
acut
diseas
link
chronic
diseas
levyleblond
et
al
addit
genet
factor
one
us
observ
host
defens
mhv
infect
requir
least
three
type
immunocompet
cell
tlymphocyt
splenic
macrophag
nklike
lymphoid
cell
tardieu
et
al
aim
present
neuropatholog
studi
better
delin
interact
mhv
differ
cell
central
nervou
system
cn
influenc
genet
background
immunolog
statu
host
particular
interest
earli
transient
leukoenceph
chronic
thrombot
vascul
later
stage
diseas
x
aj
fi
hybrid
thereaft
design
baf
mice
bred
mous
coloni
previous
describ
le
prevost
et
al
passag
assay
recoveri
mhv
perform
suscept
mice
report
previous
le
prevost
et
al
viru
titer
express
ld
tissu
viru
inject
intraperiton
ip
dose
ld
ml
salin
buffer
unless
otherwis
specifi
group
aj
strain
mice
ld
viral
suspens
inject
intracerebr
burhol
pariet
bone
total
inject
volum
gl
total
mice
inject
ninetyon
surviv
avail
studi
variou
time
infect
day
post
infect
pi
mice
anesthet
ether
perfus
left
ventricl
either
formaldehyd
wv
phosphat
buffer
optomicroscop
studi
formaldehyd
wv
phosphat
buffer
plu
glutaraldehyd
vv
electronmicroscop
studi
whole
cranium
fix
overnight
brain
remov
embed
paraffin
slice
coron
serial
basi
prepar
paraffin
section
process
convent
techniqu
seri
mice
prepar
electronmicroscop
studi
select
fragment
ependyma
white
matter
cortex
brain
stem
obtain
postfix
oso
embed
epoxi
resin
semithin
section
stain
toluidin
blue
pa
method
thin
section
stain
uranyl
acet
lead
citrat
examin
use
philip
em
electron
microscop
cyclophosphamid
treatment
cyclophosphamid
reconstitut
salin
buffer
freshli
prepar
solut
inject
ip
dose
mgkg
cyclophosphamid
treatment
semisuscept
baf
mice
given
either
mhv
infect
lead
mortal
willenborg
et
al
avoid
acut
mortal
cyclophosphamid
inject
day
pi
pi
experi
aj
strain
mice
inject
cyclophosphamid
andor
day
infect
treatment
cu
inject
ip
baf
mice
two
separ
occas
week
apart
six
week
last
inject
anim
consid
describ
previous
tardieu
et
al
mhv
inject
week
second
inject
infect
semisuscept
mice
baf
ch
surviv
develop
progress
neurolog
diseas
character
incoordin
paresi
hind
limb
enlarg
head
progress
neurolog
deterior
lead
death
within
month
group
anim
neuropatholog
chang
could
detect
examin
day
pi
first
abnorm
day
pi
consist
import
mening
infiltr
polymorphonuclear
mononuclear
cell
pi
infiltr
consist
small
lymphocyt
plasmocyt
macrophag
day
pi
diffus
mening
infiltr
diminish
progress
minim
day
pi
period
inflammatori
cuf
mening
vessel
becam
progress
mark
perivascular
inflammatori
cell
consist
small
lymphocyt
plasmocyt
macrophag
day
pi
perivascular
infiltr
mononuclear
cell
microgli
nodul
appear
hemispher
white
matter
fig
l
rare
instanc
microgli
nodul
observ
adjac
cortex
day
inflammatori
lesion
white
matter
disappear
leav
widespread
destruct
cavit
fig
b
day
pi
first
sign
ependym
appear
day
pi
granular
ependym
particularli
mark
inflammatori
lesion
predomin
fourth
ventricl
aqueduct
fig
focal
aggreg
inflammatori
cell
consist
mononuclear
cell
form
beneath
ependyma
ependym
cell
line
focal
disrupt
granuloma
bulg
ventricular
lumen
becam
even
detach
form
rosett
found
free
csf
attach
cilia
ependym
cell
electron
microscop
granulomat
bud
seen
consist
lymphocyt
histiomonocyt
togeth
ependymocyt
viral
particl
could
seen
within
affect
ependym
cell
cell
subependym
aggreg
stain
antiserum
gfap
suggest
contain
prolifer
astrocyt
chang
detect
chroid
plexu
day
pi
ependym
lesion
becam
progress
less
activ
demonstr
residu
scar
ependym
cell
line
focal
disrupt
posterior
part
fourth
ventricl
complet
destroy
prolifer
subependym
atrocyt
conspicu
fig
first
evid
ventricl
enlarg
note
pi
hydrocephalu
progress
thoughout
life
span
anim
serial
section
aqueduct
stenosi
observ
pi
mice
kill
day
pi
vascular
lesion
observ
numer
mening
arteriol
show
sever
alter
hyalin
necrosi
media
fragment
elast
lamina
intim
prolifer
fig
arteriol
capillari
occlud
inflammatori
thrombu
fig
consist
plasmocyt
polymorphonuclear
leukocyt
necrot
cell
uncertain
origin
fig
day
pi
vascul
thrombosi
seen
affect
intraparenchym
ye
fig
b
inflammatori
nodul
hemispher
white
matter
neocortex
situat
subiculum
central
white
matter
fragment
ependyma
seen
amidst
inflammatori
cell
day
pi
nissl
x
b
widespread
destruct
cerebr
white
matter
inflamm
day
pi
x
sel
beneath
iv
ventricl
dorsolater
part
brain
stem
fig
point
nervou
tissu
surround
vessel
show
distinct
sign
ischem
necrosi
character
presenc
macrophag
prolifer
astrocyt
aggreg
inflammatori
cell
seen
around
vessel
surround
parenchyma
n
microgli
nodul
intranuclear
inclus
observ
infect
semisuscept
mice
die
acut
week
show
lesion
similar
observ
fulli
suscept
mice
ie
acut
hepat
normal
appear
cn
cyclophosphamid
treatment
group
baf
mice
inject
ip
mhv
ld
two
die
acut
other
treat
cyclophosphamid
describ
materi
method
among
infect
cyclophosphamidetr
mice
surviv
two
die
day
pi
patholog
ependym
lesion
ventricular
dilat
ident
nontreat
mice
hyalin
necrosi
wall
mening
arteri
thrombosi
exist
control
contrast
mark
diminut
mening
perivascular
inflammatori
cell
infiltr
compar
control
mice
infect
mhv
treat
cyclophosphamid
evid
leukoenceph
strontium
treatment
treatment
sr
result
acut
liver
necrosi
death
day
pi
five
semisuscept
mice
test
mice
show
pattern
lesion
similar
observ
suscept
mice
six
suscept
balbc
mice
inject
ip
mhv
die
acut
hepat
necrosi
h
v
infect
neuropatholig
lesion
observ
except
slight
degre
mening
infiltr
group
balbc
mice
infect
low
dose
viru
eight
anim
die
acut
day
two
surviv
neuropatholog
lesion
ident
observ
semisuscept
mice
ie
mening
leukoenceph
ependym
ventricular
dilat
vascul
dose
inocul
viru
lower
ld
neither
acut
chronic
lesion
develop
five
inject
anim
determin
whether
resist
mice
could
develop
chronic
diseas
three
experi
perform
first
three
resist
aj
mice
inject
way
semisuscept
anim
clinic
manifest
neuropatholog
abnorm
observ
secondli
aj
strain
mice
immunosuppress
cyclophosphamid
infect
mhv
profoundli
immunosuppress
anim
two
three
cyclophosphamid
inject
mhv
infect
die
acut
previous
shown
willenborg
et
al
two
surviv
anim
slight
mening
infiltr
perivascular
infiltr
observ
pi
without
ependym
damag
third
experiment
group
mhv
inject
directli
brain
nine
mice
minim
neuropatholog
lesion
observ
light
microgli
infiltr
point
inject
without
ependym
vascular
chang
system
infect
semisuscept
strain
mice
mhv
lead
remark
sequenc
brain
lesion
mening
leukoenceph
mention
appear
first
diffus
mening
infiltr
tend
disappear
progress
within
week
without
fibrot
chang
howev
perivascular
infiltr
remain
especi
level
brain
stem
acut
leukoenceph
fig
mark
restrict
central
white
matter
cerebr
hemispher
visibl
limit
period
time
day
pi
leav
behind
sever
destruct
lesion
fig
b
type
leukoenceph
differ
white
matter
lesion
produc
mhv
consist
noninflammatori
patchi
demyelin
waksman
adam
lampert
et
al
weiner
herndon
et
al
haspel
et
al
weiner
stohlman
stohlman
weiner
presenc
glial
nodul
white
matter
occasion
adjac
cortex
may
consid
indic
direct
action
viru
glial
cell
inflammatori
chang
ependyma
appear
approxim
day
persist
month
fig
result
widespread
destruct
ependym
line
fig
viral
particl
detect
electron
microscop
ependym
cell
contrast
find
viral
ependym
nielsen
baring
wolinski
progress
hydrocephalu
start
week
pi
probabl
major
factor
death
anim
virusinduc
experiment
hydrocephalu
attribut
either
stenosi
aqueduct
produc
ependym
johnson
et
al
johnson
johnson
johnson
post
infecti
fibrosi
mening
master
et
al
anim
aqueduct
stenosi
observ
least
day
pi
mening
fibrosi
arachnoid
villi
examin
immunosuppress
semisuscept
anim
cyclophosphamid
prevent
appear
hydrocephalu
remark
effect
nearli
complet
suppress
mening
infiltr
fibrosi
mening
therefor
probabl
discount
caus
intraventricutar
hypertens
mechan
hydrocephalu
remain
unsettl
howev
parallel
intens
ependym
hydrocephalu
note
abnorm
import
baf
mice
mice
contrast
earli
selflimit
inflammatori
lesion
observ
cerebr
white
matter
ependyma
vascul
appear
late
ependym
subsid
increas
progress
thoughout
life
anim
remark
lesion
consist
hyalin
necrosi
vessel
wall
thrombos
fig
plasmocyt
remark
numer
inflammatori
thrombi
fig
perivascular
cuf
lymphocyt
plasmocyt
even
abund
earli
phase
diseas
arteriol
capillari
venul
affect
essenti
mening
surround
pon
medulla
deep
subependym
region
ivth
ventricl
within
dorsolater
part
brain
stem
small
loci
ischem
necrosi
relat
vascular
occlus
observ
fig
imposs
parenchym
lesion
could
ascrib
encephalit
process
howev
presenc
vascular
occlus
ischem
necrosi
area
unquestion
man
particularli
fetu
possibl
chronic
viral
infect
induc
ischem
brain
lesion
long
delay
slowli
progress
thrombot
vascul
suffici
consid
sequenc
event
known
howev
congenit
rubella
degener
vessel
wall
lead
multifoc
ischem
necrosi
brain
rork
spiro
singer
et
al
rork
similar
lesion
shown
experiment
anim
rork
et
al
rare
condit
granulomat
angiiti
relat
varicellazost
infect
kolodni
et
al
rosenblum
hodfield
linnemann
alvira
viral
infect
rey
et
al
man
also
known
inflammatori
perivascular
infiltr
perist
mani
month
human
poliomyel
esiri
time
vascular
lesion
develop
low
titer
viru
still
detect
brain
late
month
pi
le
prevost
et
al
dupuy
et
al
demonstr
stage
sever
non
specif
immunodepress
dupuy
et
al
investig
possibl
immun
mediat
gener
vascular
lesion
studi
effect
two
immunomodul
regimen
semisuscept
mice
cyclophosphamid
depress
tand
bcell
activ
stockman
et
al
abolish
select
nk
cell
activ
kumar
et
al
tardieu
et
al
cyclophosphamid
prevent
necrosi
vessel
wall
thrombosi
sr
treatment
chang
pattern
semisuscept
suscept
mice
die
acut
hepat
necrosi
studi
effect
preliminari
experi
perform
mice
inject
mhv
day
second
inject
avoid
acut
hepat
necrosi
intens
vascul
mice
control
ident
experi
suggest
b
nkcell
play
promin
role
induct
vascular
lesion
howev
yet
clear
evid
favor
direct
action
viru
vessel
research
need
pathogenesi
thrombot
vascul
follow
mhv
infect
neurolog
diseas
occur
fulli
suscept
mice
infect
low
dose
viru
attempt
induc
diseas
genet
resist
mice
unsuccess
even
follow
immunosuppress
intracrani
inocul
find
suggest
host
cell
brain
fulli
suscept
semisuscept
strain
equal
abl
support
viral
replic
equal
suscept
give
rise
destruct
lesion
absenc
diseas
resist
mice
may
relat
inabl
host
cell
either
bind
replic
mhv
also
possibl
mean
immunosuppress
may
alter
genet
resist
